The 2nd International Congress on Cancer Patients, held in Algiers under the patronage of Algerian President Abdelmadjid Tebboune, brought together institutions, healthcare professionals, and patient associations to discuss cancer prevention, early detection, and patient care. Organized by the Algerian Federation of Associations of Cancer Patients (FAAPAC), the congress aimed to place the patient at the heart of a comprehensive approach to cancer care. With the theme "The Patient at the Heart of a Global Approach," the congress addressed key issues in cancer prevention and treatment.
Algerian Health Minister Mohamed Seddik Aït Messaoudène announced plans to strengthen the country's radiotherapy network with 25 new services, complementing the existing 133 chemotherapy centers. He emphasized the government's commitment to ensuring a continuous supply of cancer medications, with over 73 billion Algerian dinars allocated to the National Cancer Fund, which receives an annual boost of 40 billion dinars. The minister highlighted the importance of prevention and early detection in improving cancer treatment outcomes.
The National Strategy for Cancer Prevention and Control 2025-2035, presented at the congress, focuses on five key areas: prevention, early detection, diagnosis, patient care, and research and training. Professor Adel Bounedjar, head of the National Commission for Cancer Prevention and Control, stressed the need to move from planning to concrete action in implementing the strategy. He emphasized that the goal is not only to develop a strategy but also to monitor and execute it effectively.
The congress also highlighted Algeria's progress in local production of cancer medications. Industry Minister Ouacim Kouidri announced the creation of a "green corridor" at the National Agency for Pharmaceutical Products to accelerate the registration of locally produced cancer medications. He reported that 15 establishments are licensed to produce cancer medications, with 11 already operational, producing 172 medications.
Minister of National Solidarity, Family, and Women's Condition Soraya Mouloudji emphasized the importance of social and psychological support for cancer patients and their families. She noted that her department provides support through various social structures and programs targeting vulnerable groups. The government has also made cancer medications free for low-income individuals without social insurance.
The congress brought together not only Algerian institutions and professionals but also international participants, including patient associations from several African countries and representatives of the International Union Against Cancer (UICC) and the Global Colorectal Cancer Alliance (GCCA). This international participation facilitated discussions on cooperation, experience sharing, and strengthening care networks.
The 2nd International Congress on Cancer Patients aimed to translate its vision into concrete actions, mobilizing all sectors, partners, and associations in a unified approach. FAAPAC President Hamida Kettab emphasized that the patient should be at the center of a comprehensive approach, and the congress provided a platform for stakeholders to discuss and address major issues in cancer care.
Key points
- Algerian government allocates over 73 billion dinars to National Cancer Fund
- 25 new radiotherapy services to be added to existing 133 chemotherapy centers
- Algeria produces 172 cancer medications locally, with 15 licensed establishments operational
